Martin Brenner - May 9, 2024 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Executive Officer and Chief Scientific Officer
Signature
/s/ Martin Brenner
Stock symbol
IBIO
Transactions as of
May 9, 2024
Transactions value $
$0
Form type
4
Date filed
5/13/2024, 04:32 PM
Previous filing
Nov 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +147K $0.00 147K May 9, 2024 Common Stock 147K $1.88 Direct F1
transaction IBIO Stock Option (right to buy) Award $0 +110K $0.00 110K May 9, 2024 Common Stock 110K $1.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.
F2 These options vest in equal amounts on a quarterly basis over a 36-month period commencing on the date of grant.

Remarks:

Chief Executive Officer and Chief Scientific Officer